Stocks / NASDAQ / Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporation

Our Opinion

Nymox Pharmaceutical Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in research and development of some of their medical products.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“Drug candidates that look promising in early studies in the laboratory or with animals often prove on further testing to be unsafe, ineffective or impractical to use with human patients.” (Page 22) Read the full document

Company Description

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which specializes in the research and development of products for the aging population. The company markets NicAlertTM and TobacAlertTM, tests that use urine or saliva to detect use of tobacco products. It develops NX-1207, a novel treatment for benign prostatic hyperplasia, which is in Phase 3 clinical trials. Nymox Pharmaceutical was founded by Paul Averback on May 30, 1995 and is headquartered in Saint-Laurent, Canada. [Source: MarketWatch]

Company Website: